Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun;19(3 Epilepsy):756-66.
doi: 10.1212/01.CON.0000431396.23852.56.

Dietary treatment of intractable epilepsy

Affiliations
Review

Dietary treatment of intractable epilepsy

Mackenzie C Cervenka et al. Continuum (Minneap Minn). 2013 Jun.

Abstract

Purpose of review: Dietary therapies for seizure management date back further than pharmacologic interventions, but many neurologists are not familiar with these treatment options. This introduction to dietary therapies will discuss administration of ketogenic diets, comparisons between diet types, evidence-based efficacy of diet therapies in epilepsy treatment, and management of side effects. This review will provide the general neurologist with the skills to identify appropriate candidates for these treatments and to offer comprehensive ongoing care.

Recent findings: In adults and children with medically resistant epilepsy, studies have consistently shown a greater than 50% reduction in seizure frequency in approximately one-half of patients within days to months after starting dietary therapy.

Summary: Dietary treatment options for epilepsy include the classic ketogenic diet, the medium-chain triglyceride diet, the modified Atkins diet, and the low glycemic index treatment. These were first used to control seizures in children with intractable epilepsy, but in recent years have also been demonstrated to be safe and effective in children and adults with a broad range of seizure types and are being used with increased frequency worldwide.

PubMed Disclaimer

Figures

Figure 11-1.
Figure 11-1.
Potential antiepileptic mechanisms of action of ketogenic diets. Ketone bodies produced during treatment with ketogenic diets may influence the metabolic pathways of several neurotransmitters including γ-aminobutyric acid (1, 4), glutamate (2, 5), adenosine (3), norepinephrine (3), and the Krebs cycle (6). GABA = γ-aminobutyric acid; GLN = glutamine; GLU = glutamate; ROS = reactive oxygen species; GABABR = γ-aminobutyric acid β receptor; GABAAR = γ-aminobutyric acid α receptor, Cl = chloride; VGLUT = vesicular glutamate transporter; KATP = potassium adenosine triphosphate; A1R = adenosine receptor. Reprinted with permission from McNally MA, Hartman AL, J Neurochem. © 2012 International Society for Neurochemistry. onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2012.07670.x/abstract.

References

    1. Hippocrates. On the sacred disease. In: Adams F, trans. The genuine works of Hippocrates. Baltimore, MD: The Williams & Wilkins Company, 1939: 347–360.
    1. Guelpa G,, Marie A. La lutte contre l’epilepsie par la desintoxication et par la reducation alimentaire. Rev de Therap Med-Chir 1911; 78: 8–13.
    1. Kossoff EH,, Freeman JM,, Turner Z,, Rubenstein J. Ketogenic diets: treatments for epilepsy and other disorders. 5th ed. New York, NY: Demos Medical Publishing, 2011.
    1. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin Proc 1921; 2: 307–308.
    1. Huttenlocher PR,, Wilbourne AJ,, Singmore JM. Medium chain triglycerides as a therapy for intractable childhood epilepsy. Neurology 1971; 21 (11): 1097–1103. - PubMed